Pharmacogenetics and geographical ancestry: implications for drug development and global healthDAAR, Abdallah S; SINGER, Peter A.Nature reviews. Genetics (Print). 2005, Vol 6, Num 3, pp 241-246, issn 1471-0056, 6 p.Article

A Population Pharmacokinetic-Pharmacogenetic Analysis of AtazanavirKILE, Deidre A; MAWHINNEY, Samantha; AQUILANTE, Christina L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1227-1234, issn 0889-2229, 8 p.Article

Pharmacogenetic profiling might meet the challengeJOLOBE, Oscar M. P.Journal of internal medicine. 2011, Vol 270, Num 5, pp 494-495, issn 0954-6820, 2 p.Article

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation: characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiencyDAYER, P; KRONBACH, T; EICHELBAUM, M et al.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4145-4152, issn 0006-2952Article

Pharmacogenetics of opioidsSOMOGYI, Andrew A; BARRATT, Daniel T; COLLER, Janet K et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 3, pp 429-444, issn 0009-9236, 16 p.Article

Pharmacogenetics: potential for individualized drug therapy through geneticsJOHNSON, Julie A.Trends in genetics (Regular ed.). 2003, Vol 19, Num 11, pp 660-666, issn 0168-9525, 7 p.Article

Les actualités sur la pharmacogénétiqueBECQUEMONT, Laurent.La Lettre du pharmacologue (Boulogne). 2013, Vol 27, Num 3, issn 0984-452X, 24 p.Serial Issue

Pharmacogenetics : From Bench to ByteSWEN, J. J; WILTING, I; KOOPMANS, R et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 5, pp 781-787, issn 0009-9236, 7 p.Article

Pharmacogenetics : focus on pharmacodynamicsLINDPAINTNER, Klaus; FOOT, Elizabeth; CAULFIELD, Mark et al.International journal of pharmaceutical medicine. 2001, Vol 15, Num 2, pp 74-82, issn 1364-9027Article

Challenges in pharmacogeneticsCASCORBI, Ingolf; BRUHN, Oliver; WERK, Anneke N et al.European journal of clinical pharmacology. 2013, Vol 69, issn 0031-6970, S17-S23, SUP1Article

Pharmacosynthetics: Reimagining the pharmacogenetic approachFARRELL, Martilias S; ROTH, Bryan L.Brain research. 2013, Vol 1511, pp 6-20, issn 0006-8993, 15 p.Article

PHARMACOGENETICS: PART IGIBALDI, Milo.The Annals of pharmacotherapy. 2007, Vol 41, Num 12, pp 2042-2047, issn 1060-0280, 6 p.Article

ADRIS: The Adverse Drug Reactions Information schemeHUG, Hubert; BAGATTO, Dario; DANNECKER, Robert et al.Pharmacogenetics (London). 2003, Vol 13, Num 12, pp 767-772, issn 0960-314X, 6 p.Article

Validating and Using Pharmacogenomics: Joint IFCC-Roche Diagnostics Conference, Kyoto, Japan, 16-19 April 2000Clinical chemistry and laboratory medicine. 2000, Vol 38, Num 9, issn 1434-6621, 143 p.Conference Proceedings

Developing Pharmacogenetic Evidence Throughout Clinical DevelopmentBURNS, D. K.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 6, pp 867-870, issn 0009-9236, 4 p.Article

Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chipsNAKAMOTO, Kaori; KIDD, Judith R; JENISON, Robert D et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 2, pp 103-114, issn 1744-6872, 12 p.Article

Pharmacogenetics/genomics and personalized medicineSADEE, Wolfgang; ZUNYAN DAI.Human molecular genetics (Print). 2005, Vol 14, pp R207-R214, issn 0964-6906, NSArticle

Pharmacogenetics and the regulation of gene transcriptionGRANT, Denis M.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 391-393, issn 0960-314X, 3 p.Article

Pharmacogenetics: five decades of therapeutic lessons from genetic diversityMEYER, Urs A.Nature reviews. Genetics (Print). 2004, Vol 5, Num 9, pp 669-676, issn 1471-0056, 8 p.Article

Pharmacogenetics : its biologic roots and the medical challengeKALOW, W.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 3, pp 235-241, issn 0009-9236Article

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsALVAN, G; BECHTEL, P; ISELIUS, L et al.European journal of clinical pharmacology. 1990, Vol 39, Num 6, pp 533-537, issn 0031-6970, 5 p.Article

Polymorphisms of antipyrine and theophylline metabolism in man: molecular and clinical implicationsVESELL, E. S.Xenobiotica (London. Print). 1986, Vol 16, Num 5, pp 401-420, issn 0049-8254Article

Family studies of mephenytoin hydroxylation deficiencyINABA, T; JURIMA, M; KALOW, W et al.American journal of human genetics. 1986, Vol 38, Num 5, pp 768-772, issn 0002-9297Article

Addressing the Challenges of the Clinical Application of Pharmacogenetic TestingIKEDIOBI, O. N; SHIN, J; NUSSBAUM, R. L et al.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 1, pp 28-31, issn 0009-9236, 4 p.Article

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centersLÖTSCH, Jörn; VON HENTIG, Nils; FREYNHAGEN, Rainer et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 6, pp 429-436, issn 1744-6872, 8 p.Article